Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma.

Cancer·2026

Same author

Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.

Research and practice in thrombosis and haemostasis·2026

Same author

Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patients.

Journal of neurosurgery·2026

Same author

Dose-Dependent Effects of Radiation on the Coronary Arteries: Results From a Preclinical Model of Single-Fraction Proton Beam Cardiac Radioablation.

Circulation. Arrhythmia and electrophysiology·2025

Same author

Early and Late Myocardial Effects of Proton Beam Cardiac Radioablation: Insights From Gene Expression Analysis.

JACC. Clinical electrophysiology·2025

Search research articles

Related Experiment Video

Updated: May 17, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

The clinical case for proton beam therapy.

Robert L Foote¹, Scott L Stafford, Ivy A Petersen

¹Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. foote.robert@mayo.edu

Radiation Oncology (London, England)

|October 23, 2012

Summary

Proton beam therapy offers improved tumor control and reduced normal tissue damage compared to conventional radiation. Further research is needed to identify patient groups who benefit most from this advanced treatment.

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Related Experiment Videos

Last Updated: May 17, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Area of Science:

Oncology
Radiation Physics
Medical Technology

Background:

Proton beam therapy programs have expanded in the US over the last two decades.
The development of new proton therapy centers is increasing.
This advanced radiation modality presents opportunities for improved cancer treatment outcomes.

Purpose of the Study:

To review the clinical evidence supporting the use of proton beam therapy.
To discuss the potential benefits of proton therapy in cancer treatment.
To highlight areas for future clinical research in proton beam therapy.

Main Methods:

Review of existing clinical research and program implementation data.
Analysis of the comparative benefits and costs of proton beam therapy versus conventional x-ray therapy.
Discussion of the potential impact on tumor control, normal organ toxicity, and quality of life.

Main Results:

Proton beam therapy can potentially improve tumor control via dose escalation.
It may reduce harm to surrounding healthy tissues through precise dose delivery.
While more expensive, cost offsets may arise from better functional outcomes and fewer late effects.

Conclusions:

Proton beam therapy is a promising, technically advanced radiation treatment.
Clinical research is essential to define optimal patient selection for maximizing benefits.
Further investigation is warranted to fully establish the value proposition of proton therapy.